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Brief Definitive Report 
INFLUENZA V IRUS SUBTYPE-SPECIF IC  CYTOTOXIC  T 
LYMPHOCYTES LYSE TARGET CELLS COATED WITH A 
PROTEIN  PRODUCED IN E. COLI 
BY AKIO YAMADA,* JAMES F. YOUNG, * AND FRANCIS A. ENNIS* 
From the *Division of Infectious Disease, Department ofMedicine, University of Massachusetts 
Medical School, Worcester, Massachusetts 01605; and the *Molecular Genetics Division, Smith, 
Kline, and French Laboratories, Philadelphia, Pennsylvania 19101 
Virus-specific ytotoxic T cells (CTL) recognize viral antigen in conjunction 
with products of genes of the major histocompatibility complex (MHC) (1); 
however, the nature of the viral antigen(s) recognized by specific CTL is not 
clear, identification of viral determinant(s) recognized by CTL is an important 
issue; however, it has been difficult to demonstrate CTL recognition of target 
cells exposed to viral antigens. Previous tudies (2) have indicated that the surface 
glycoproteins of Sendal virus were recognized by CTL, providing the fusion (F) 
protein was cleaved. Isolated viral surface glycoproteins were recognized on cell 
surfaces by CTL after incorporation i to the cell membrane by liposomal carriers 
(3, 4), and by DNA-mediated gene transfer (5). CTL responses to internal 
influenza viral proteins have also been reported (6, 7). Extensive studies have 
been conducted (8) using influenza A virus infection as a model system, and two 
different subpopulations of CTL, crossreactive and subtype-specific, are induced. 
We previously reported (9) that an influenza virus-specific polypeptide (des- 
ignated c13 protein) produced in E. coli induced H1 influenza subtype-specific 
memory and secondary H-2-restricted CTL responses in mice. The cl 3 protein 
is a hybrid protein of the first 81 amino acids of the NS1 viral nonstructural 
protein and the HA2 subunit of viral hemagglutinin (HA) derived using genes 
from an H1 N1 virus. It is, therefore, conceivable that the c l 3 protein interacts 
with cellular membrane to be presented to CTL precursors along with MHC 
products. In this study, we examined the ability of c 13 protein to render target 
cells susceptible to lytic activity of influenza virus-specific CTL. The results 
showed that target cells exposed to c 13 protein were lysed by CTL in a subtype- 
specific and H-2-restricted manner, suggesting that this protein interacts with 
target cell membrane with its hydrophobic region, and is presented on the cell 
membrane in proper conformation with H-2 antigens for recognition by the 
influenza virus subtype-specific CTL. 
Materials and Methods 
Mice. Male BALB/cAnH (H-2 d) and C3H/HeN (H-2 k) mice were purchased from 
Charles River Breeding Laboratories, Inc. (Wilmington, MA), and used at the age of 4- 
5 wk. 
Virus. Influenza A viruses, PR8 (A/Puerto Rico/8/34 [H 1N 1 ]), A/BZ (A/Brazil/11/78 
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[H1NI]), A/PC (A/Port Chalmers/l/73 [H3N2]), and a recombinant virus A/X31 
(H3N2), were propagated in 9-d-old embryonated chicken eggs, as described previously 
(9). 
Production ofcl3 Protein. c13 protein was produced in E. coli as described before (9). 
Briefly, plasmids containing DNA fragments complementary to the viral RNA of PR8 
virus were manipulated toachieve xpression of c 13 protein, which is a hybrid of the first 
81 amino acids of NSl and HA2. Following lysis of the bacteria, two 0.1% deoxycholate 
extractions and one 1% Triton X-100 extraction were performed to remove contaminat- 
ing E. coli proteins, and the c13 protein was solubilized with 4 M urea (4°C for 30 rain). 
The urea was then removed by dialysis at 4°C and stored in 50 mM Tris-HCl, pH 8.0, 1 
mM EDTA. 
Induction of Secondary CTL In Vitro. Secondary CTL were prepared as described 
previously (9). Briefly, spleen cells from mice immunized with virus were cultured with 
syngeneic normal spleen cells infected with the virus or exposed to c13 protein (12.5 
#g/ml) at 37°C for 5 d. After several washings, they were used as effector cells. 
CTL Assay. P815 cells (H-2 d) and BW5147 cells (H-2 k) were used as target cells. In 
preliminary experiments, we observed that P815 and BW5147 cells exposed to c13 
protein (12 ~g/ml) expressed membrane antigen(s), detected by indirect immunofluores- 
cence with a specific antiserum to c13 protein, but P815 and BW5147 cells not treated 
with c13 did not. In the CTL assay, target cells infected with virus, or exposed to c13 
protein diluted in RPMI medium, were labeled with Na25~CrO4, and incubated with 
effector cells at various effector/target (E/T) ratios in a 96-well round-bottom icroplate 
at 37°C for 4 h in a standard 51Cr-release assay, as described earlier (9). 
Cold-target Inhibition Test. P815 cells infected with various viruses or treated with c 13 
protein (12.5 t~g/ml) at 37°C for 90 min were added to the CTL assay at various 
concentrations. The CTL assay was performed as described below. 
Blocking of Cytotoxicity by Anti-H-2 a Monoclonal Antibody (mAb). Various target cells were 
incubated with anti-H-2 amAb (Litton Bionetics, Charleston, SC) at 37°C for 30 rain, and 
then were incubated with appropriate effector cells at 37°C for 4 h. Antibody was used 
at 1:20 dilution (final), based on the results of a preliminary experiment. Cytotoxicity was 
determined as described above. 
Results 
Influenza Virus-specific Lysis of Target Cells Exposed to c13. We examined the 
ability of c 13 protein to render P815 cells susceptible to influenza virus-specific 
CTL.  Effector cells were generated by stimulation of  PR8 virus- immune spleen 
cells with PR8 virus-infected syngeneic spleen cells, and by c13 protein. As 
shown in Fig. 1, c13 protein-coated P815 cells were lysed by PR8 virus- and 
c l 3 protein- induced CTL,  although the level of lysis was below that of virus- 
infected target cells. The  level of lysis of cl 3 protein-coated target cells was 
dose-dependent up to a concentration of 3 ~g/ml (data not shown). These results, 
(Fig. 1) suggested that target cells exposed to c 13 protein displayed an H 1 virus 
subtype-specific determinant, since c13 protein has been shown (9) to induce 
H1 subtype-specific CTL.  We therefore prepared two different effector cells, 
PR8 virus-stimulated PR8 virus- immune spleen cells, and A/PC virus-stimu- 
lated A/PC virus- immune spleen cells. Both PR8-immune effectors and PC- 
immune effectors pecifically lysed PR8 virus-infected target cells; (e.g., 63.8% 
and 66.2%, respectively, at E /T  ratios of 10:1); however, c13 protein-coated 
target cells showed little lysis by A/PC virus- induced A/PC virus- immune spleen 
cells, (2.8% at E /T  10:1), whereas they were definitely susceptible to PR8 virus- 
stimulated PR8 virus- immune spleen cells (34.0% at E /T  10:1). These findings 
suggest hat c13 protein-coated target cells were lysed by PR8 virus-specific 
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FmUaE 1. Lysis of P815 target cells infected with PR8 virus, exposed to c13 protein, or 
untreated target cells (Nil). These target ceils were incubated with PR8virus-immune spleen 
cells stimulated with virus (©) or c13 protein (A). Unstimulated PR8 virus-immune spleen 
cells (l-I) were also used as effectors. 
Cold-target Inhibition Study. To further examine the antigen specificity of 
effector cells recognizing target cells coated with c 13 protein, we tried to inhibit 
the killing activity of  effector cells by cold target cells. Lysis of  c13 protein- 
coated 51Cr-labeled target cells was inhibited by both PR8 virus- and A/BZ 
virus-infected cold target cells, as well as by c13 protein-coated target cells (Fig. 
2). A/X31 virus-infected "~lCr-labeled target cells were not lysed by PR8 virus- 
induced effector cells in the presence of all cold target cells infected with type A 
viruses, but were lysed in the presence of c 13 protein-coated or uninfected cold 
target cells. These findings indicate that c13 protein-coated target cells are 
recognized and lysed by H 1 virus subtype-specific CTL. 
H-2-restricted Killing of c13 Protein-coated Target Cells. We attempted to 
determine whether there was H-2 restriction of killing of c13 protein-coated 
target cells. Effector cells were obtained from BALB/c (H-2 d) and C3H (H-2 k) 
mice immunized with PR8 virus at least 3 wk before. After stimulation with 
virus-infected syngeneic spleen cells, cytotoxicity was examined on virus-infected 
and c13 protein-coated P815 (H-2 a) and BW5147 (H-2 k) cells. Table I shows 
that the lysis of virus-infected target cells was definitely restricted by the H-2 
complex. The lysis of P815 cells coated with c13 protein was manifested by 
effector cells from BALB/c mice, but not by those from C3H mice. To further 
examine a possible association of c13 protein with the H-2 a molecule, we 
attempted to block the killing of c 13 protein-coated P815 cells by H-2 d effector 
cells using mAb directed to H-2K d and -D a. As shown in Table II, the lysis of 
P815 cells infected with PR8 virus by BALB/c-derived effector cells was reduced 
in the presence of anti-H-2 d mAb. The anti-H-2 d mAb inhibited BALB/c effec- 
tor-mediated lysis o fc l  3 protein-coated P815 cells, but did not affect the killing 
of PR8 virus-infected BW5147 cells by C3H-derived effectors. These results 
strongly suggest hat c l 3 protein is recognized by influenza virus-specific CTL 
in conjunction with H-2K a or  -D  d molecules. BW5147 cells coated with c13 
protein were not sensitive to the lytic activity of C3H-derived effector cells, even 
though they could lyse PR8 virus-infected BW5147 cells (Table I). 
Discussion 
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F]6VRE 2. Cold-target inhibition test. Lysis o fc l3  protein-coated P815 cells by PR8 virus- 
stimulated PR8 virus-immune spleen cells was examined in the presence of various cold target 
cells. 51Cr-labeled P815 cells infected with A/X31 virus were also included in this experiment. 
TABLE I 
H-2-restricted Lysis of cl3 Protein-coated P815 Cells 
Target E/T ratio 
Percent specific lysis by 
effectors* 
BALB/c 





30 57.2 -1.6 
10 55.3 0.0 
3 36.1 0.0 
30 34.6 1.8 
10 21.0 1.2 
3 11.8 -2.2 
30 2.6 38.7 
10 -1.6 31.8 
3 1.2 17.9 
30 0.5 4.6 
10 -1.7 0.0 
3 -1.3 -1 .2 
* Obtained by subtraction of lysis of untreated target cells by each group of effector 
cells. 
protein of the first 81 amino acids of NS1 and HA2 of PR8 virus, are lysed by 
influenza virus-specific CTL. Lysis of c 13 protein-coated target cells was accom- 
plished by CTL induced by virus strains of the H 1 but not the H3 subtype. Cold- 
target inhibition analysis clearly demonstrated that c13 protein-coated target 
cells were recognized and killed by an H 1 subtype-specific population of CTL, 
confirming our previous finding (9) that cl 3 protein has a determinant recog- 
nized by H 1 subtype-specific CTL. 
Morein et al. (3) showed that liposomes containing the surface glycoproteins 
of Semliki Forest virus could sensitize target cells to CTL in the presence of 
inactivated Sendai virus. Sendal virus, which has a potent protein, UV-inactivated 
virions (2), and the hemagglutinin-neuraminidase (HN) and F proteins, have 
been shown (4) to make target cells sensitive to CTL killing when introduced 
into target cells in liposome vehicles. Koszinowsky et al. (10) reported killing 
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TABLE I I  
Effect of Anti-H-2 a mAb on Lysis of cl3 Protein-coated Target Cells 
Percent specific lysis in the 
Effector Target E/T ratio presence of:* 
SP2/0 Anti-H-2 a 
BALB/c PR8-P815 10 57.4 48.9 (14.8) 
3 41.4 36.2 (12.6) 
c13-P815 30 43.3 26.8 (38.1) 
10 22.2 10.6 (52.3) 
3 9.3 6.9 (25.8) 
C3H PR8-BW5147 10 48.0 45.5 (5.2) 
3 22.3 23.0(-3.1) 
* PR8 virus-infected and c- 13 coated target cells were incubated with a 1:20 dilution 
of anti-H-2 dmAb, or with the supernatant fluid obtained from culture of parental 
SP2/0 cells at 37°C for 30 min, then incubated with effector cells. Percent 
inhibition of killing is indicated in the parentheses. 
to liposomes containing influenza virus surface glycoproteins, HA and neuramin- 
idase (NA). 
As far as we know, there have been no successful reports of making target 
cells sensitive to CTL specific for viral proteins without using liposomes. In this 
regard, it was somewhat unexpected to observe killing of c13 protein-coated 
P815 cells. The HA2 portion of c 13 protein has a long hydrophobic tail on its 
carboxy-terminal end (11); therefore, it is conceivable that this hydrophobic end 
can be embedded into the plasma membrane, although we do not know the 
precise mechanism of the interaction of c 13 protein with the cellular membrane. 
The observation (12) that the tryptic peptide of hen's egg lysozyme, which has a 
hydrophobic portion, could be presented by fixed macrophages to T cell clones 
seems to support his concept. 
The observation that C3H (H-2 k) mouse effector cells with the ability to lyse 
PR8 virus-infected BW5147 (H-2 k) cells did not lyse c13 protein-coated P815 
(H-2 d) cells suggests that lysis of c13 protein-coated target cells was H-2 re- 
stricted. The association of c 13 protein with an H-2 molecule was also suggested 
by a blocking experiment using mAb against H-2K d and -D d molecules. On the 
other hand, it is of interest hat c 13 protein-coated BW5147 cells were resistant 
to CTL derived from both H-2-compatible and -incompatible mice. Since c l 3 
protein could be detected on the surface of BW5147 cells by immunofluorescent 
study using specific antibody to cl 3 protein (our unpublished observation), it is 
conceivable that influenza virus-specific, H-2k-restricted CTL cannot recognize 
c13 protein in conjunction with H-2 k molecules. Selected use of certain H-2 
molecules as restriction elements by CTL has been reported (13). 
In conclusion, we have demonstrated that a particular protein produced in E. 
coli renders target cells susceptible to influenza virus H 1 subtype-specific CTL. 
These approaches should provide us with more details concerning the antigenic 
specificity of virus-specific CTL and the interaction between viral antigen(s) and 
MHC product(s). 
Summary 
We have tested the ability of the c 13 protein, which is a hybrid protein of the 
first 81 amino acids of the viral nonstructural protein (NS1) and the HA2 subunit 
of viral hemagglutination produced in E. coli, to render target cells susceptible 
to the lytic activity of influenza virus-specific ytotoxic T lymphocytes (CTL). 
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virus- induced secondary CTL  derived from BALB/c mice. Cold-target inhibi- 
tion tests clearly demonstrated that c l 3 protein-coated P815 cells were recog- 
nized by an H1 subtype-specific CTL  population. Furthermore,  PR8 virus- 
induced CTL  derived from C3H mice did not lyse c13 protein-coated P815 
cells, suggesting that cl 3 protein was recognized by CTL  in conjunction with H- 
2 d products. These findings suggest hat this protein interacts with the cellular 
plasma membrane and makes target cells recognizable by H-2-restricted, influ- 
enza virus subtype-specific CTL.  
Received for publication 18June 1985 and in revised form 14 August 1985. 
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